Szabó A, Hake P, Salzman A L, Szabó C
Division of Critical Care, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Crit Care Med. 1999 Jul;27(7):1343-50. doi: 10.1097/00003246-199907000-00027.
In rodent models, enhanced formation of nitric oxide and formation of peroxynitrite have been implicated in the pathogenesis of various forms of shock. Here we examined the effect of mercaptoethylguanidine (MEG), an inducible nitric oxide synthase inhibitor and peroxynitrite scavenger, in a severe hemorrhagic shock model.
Randomized, placebo-controlled trial.
Animal laboratory.
Twenty-one anesthetized immature Yorkshire pigs.
Mechanical ventilation, sternotomy, continuous cardiac output (pulmonary artery flowmetry), and systemic and intracardial pressure measurements were taken. Pigs were bled to a cardiac index of 40 mL/kg/min for 2 hrs, which was followed by saline resuscitation (20 mL/kg). MEG was administered in the resuscitation fluid (15 mg/kg bolus plus 15 mg/kg/hr infusion).
Hemodynamic variables, systemic and mixed venous blood gas tensions and oxygenation, arterial lactate concentration, myeloperoxidase activity, malondialdehyde content, and histologic injury in the lung and intestine were measured. Reduction of cardiac output to 40 mL/kg/min led to the following changes during hypovolemia: decreases in mean arterial blood pressure (to 30-35 mm Hg), both atrial pressures, systemic oxygen consumption (by 35%), mixed venous saturation (by 65%), and lactic acidosis (5.5-6.0 mM). Fluid replacement failed to restore blood pressure and cardiac output during resuscitation and was followed by gradual hemodynamic decompensation. Hemorrhagic shock induced lipid peroxidation, neutrophil deposition, and severe histologic alterations in the lung and intestine. MEG significantly ameliorated the decrease in blood pressure and cardiac output during resuscitation, improved survival rate, reduced lipid peroxidation in the intestine, and ameliorated neutrophil accumulation in the lung and intestine. MEG prevented the reduction in oxygen consumption during resuscitation.
When given during resuscitation, MEG exerted beneficial effects in a porcine model of severe hemorrhagic shock. We propose that the mode of MEG's action is related to improved cardiac contractility.
在啮齿动物模型中,一氧化氮生成增加和过氧亚硝酸盐形成与各种形式休克的发病机制有关。在此,我们在严重失血性休克模型中研究了诱导型一氧化氮合酶抑制剂和过氧亚硝酸盐清除剂巯基乙基胍(MEG)的作用。
随机、安慰剂对照试验。
动物实验室。
21只麻醉的未成熟约克夏猪。
进行机械通气、胸骨切开术、连续心输出量(肺动脉血流测量)以及全身和心内压测量。将猪放血至心脏指数为40 mL/kg/min,持续2小时,随后用生理盐水复苏(20 mL/kg)。在复苏液中给予MEG(15 mg/kg推注加15 mg/kg/小时输注)。
测量血流动力学变量、全身和混合静脉血气张力及氧合、动脉乳酸浓度、髓过氧化物酶活性、丙二醛含量以及肺和肠道的组织学损伤。在心输出量降至40 mL/kg/min期间,低血容量时出现以下变化:平均动脉血压降低(至30 - 35 mmHg)、双房压降低、全身氧耗量降低(35%)、混合静脉饱和度降低(65%)以及乳酸性酸中毒(5.5 - 6.0 mM)。复苏期间补液未能恢复血压和心输出量,随后出现逐渐的血流动力学失代偿。失血性休克诱导脂质过氧化、中性粒细胞沉积以及肺和肠道严重的组织学改变。MEG显著改善复苏期间血压和心输出量的降低,提高存活率,减少肠道脂质过氧化,并改善肺和肠道中的中性粒细胞积聚。MEG防止复苏期间氧耗量的降低。
在复苏期间给予MEG,对严重失血性休克猪模型具有有益作用。我们认为MEG的作用方式与改善心脏收缩力有关。